The dual challenge of diabesity: pathophysiology, management, and future directions
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-05 · 398 (5) · 4891-4912
DOI: 10.1007/s00210-024-03713-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 16.12.2024. Verfasst von Ritika Sindhwani und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Pharma Sciences, Chandigarh University, Mohali, 140413, Punjab, India. Hauptthemen laut MEDLINE: Obesity, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 187 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Institute of Pharma Sciences, Chandigarh University, Mohali, 140413, Punjab, India.
- University Institute of Pharma Sciences, Chandigarh University, Mohali, 140413, Punjab, India. kundanresearch1381@gmail.com.
Zitieren
APA
Sindhwani, R., Bora, K. S., & Hazra, S. (2025). The dual challenge of diabesity: pathophysiology, management, and future directions. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(5), 4891-4912. https://doi.org/10.1007/s00210-024-03713-4
Vancouver
Sindhwani R, Bora KS, Hazra S. The dual challenge of diabesity: pathophysiology, management, and future directions. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(5):4891-4912. doi:10.1007/s00210-024-03713-4
BibTeX
@article{Sindhwani2025,
author = {Sindhwani, Ritika and Bora, Kundan Singh and Hazra, Subhajit},
title = {The dual challenge of diabesity: pathophysiology, management, and future directions},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {5},
pages = {4891--4912},
doi = {10.1007/s00210-024-03713-4}
}
EUVIMED